Hennenlotter, Jörg
University of Tübingen
2 papers on CoChatORCID 0000-0003-3827-6996
Most cited papers
- Verified
Promiscuous survivin peptide induces robust CD4+ T‐cell responses in the majority of vaccinated cancer patients
Widenmeyer, M., Griesemann, H., Stevanović, S., Feyerabend, S., Klein, R., Attig, S., Hennenlotter, J., Wernet, D., Kuprash, D. V., Sazykin, A. Y., et al. (2012) · International Journal of Cancer
Immunotherapy and Immune Responsesvaccines and immunoinformatics approaches
Cited by 70
- Verified
Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA‐B44 supertype
Hillen, N., Mester, G., Lemmel, C., Weinzierl, A. O., Müller, M., Wernet, D., Hennenlotter, J., Stenzl, A., Rammensee, H., & Stevanović, S. (2008) · European Journal of Immunology
vaccines and immunoinformatics approachesImmunotherapy and Immune Responses
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free